В ходе подготовки статей по инфарктам миокарда для пользователей сайта МедикалПланет использованы труды следующих авторов:

1. Alexander R. W., Pratt С. М., Roberts R. Diagnosis and management of patients with acute myocardial infarction. In: Alexander R. W., Schlant R. C., Fuster V., O’Rourke R. A., Roberts R., Sonnenblick E. H. (eds). Hurst’s The Heart, 9th ed. New York, McGraw-Hill, 1998:1345-1433.
2. Antman Е. M.,Tanasijevic,M.J., Thompson B.etal. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med., 1996; 335:1342-1349.
3. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than one-thousand patients. Lancet, 1994; 343:311-322.
4. Fuster V., Badimon L., Badimon J. J., Chesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N. Engl. J. Med., 1992; 326: 310-318.
5. GUSTO IIA Investigators, Ohman E. M., Armstrong P. W., Christenson R. H. et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N. Engl.J. Med., 1996; 335:1333-1341.
6. Hochman J. S., Boland J., Sleeper L. A. et al. Current spectrum of cardiogenetic shock and effect of early revascularization on mortality: results of an International Registry. SHOCK Registry Investigators. Circulation, 1995; 91:873-881.
7. Kinch J. W., Ryan T. J. Right ventricular infarction. N. Engl.J. Med., 1994; 330: 1211-1217. ‘
8. Pfeffer M. A., Braunwald E., Moye L. A. et al. Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N. Engl.J. Med., 1992; 327:669-677.
9. Puleo P. R., Meyer D., Wathen C. et al. Use of rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N. Engl.J. Med., 1994; 331:561-566.
10. Ryan T. J., Anderson J. L., Antman E. M. et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J. Am. Coll. Cardiol., 1996; 28:1328-1428.
11. Sacks F. M., Pfeffer M. A., Moye L. A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Trial Investigators. N. Engl.J. Med., 1996; 335:1001-1009.
12. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994; 344:1383-1389.
13. Wenger N. K. Rehabilitation of the patient with coronary heart disease. In: Alexander R. W., Schlant R. C., Fuster V., O’Rourke R. A., Roberts R., Sonnenblick E. H. (eds). Hurst’s The Heart. New York, McGraw-Hill, 1998:1619-1631.

- Вернуться в оглавление раздела "Кардиология."